Mechanistically, SNGH14 promotes microglial activation by regulating phospholipase A2 group IVA signalling by sponging miR‐145‐5p in cerebral infarction.18 Liu et al, showed that SNHG14 enhances progression of gastric cancer via modulating miR‐145/ SRY‐box 9 signalling.19 In breast cancer, SNHG14 induces chemoresistance via regulating poly(A) binding protein cytoplasmic 1 expression through H3K26 acetylation.21 These results suggest that SNHG14 regulates distinct signalling pathways in a cancer‐type dependent manner. The gene discussed is PABPC1; the disease is breast carcinoma.